Intensity Therapeutics, Inc
Intensity Therapeutics, Inc., based in Shelton, CT, is a biotechnology company focused on developing innovative intratumoral delivery technologies to improve cancer treatment outcomes. Their proprietary DfuseRx platform allows for the targeted injection of therapeutic agents directly into solid tumors, enhancing drug absorption and activating systemic immune responses against cancer.
The company's lead product, INT230-6, aims to prolong the survival of patients with metastatic cancer while also addressing disease recurrence in presurgical cases. Through their research, Intensity Therapeutics strives to significantly extend patients' lives while maintaining their quality of life.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.